Artificial intelligence and automation are increasingly shaping the preclinical CRO market. Drug developers need faster, more reliable, and more efficient ways to assess drug candidates before they enter human testing.
AI can help researchers analyze large datasets, identify potential drug targets, predict molecular properties, and improve study design. Automated systems can support...
Bangla